Volume 11, Number 4, 307-312, DOI: 10.1007/BF00422396

Published in partnership with the

Logo

European Association for the Study of Diabetes

Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy

D. Bensoussan, S. Levy-Toledano, P. Passa, J. Caen and J. Canivet

View Related Documents

Abstract

In 18 insulin-dependent diabetics (6 without retinopathy, 6 with proliferative retinopathy and 6 with proliferative retinopathy treated by hypophysectomy) matched for age and duration of diabetes, in vitro haemostasis was studied using ADP induced platelet aggregation, ristocetin induced platelet aggregation which allows von Willebrand factor (VIII VWF) assay, and determination of antihemophilic factor procoagulant activity (VIII AHF). Using gel filtration-isolated platelets, the ADP induced hyperaggregation previously reported in diabetics with severe retinopathy untreated by hypophysectomy appeared to be related to a platelet and not a plasma factor; the normal results of thrombin induced aggregation suggests that the presumed abnormal platelet factor is related to the platelet plasma membrane. High level of plasma VIII VWF was observed in diabetics with proliferative retinopathy while the VIII AHF level was within normal limits.

Key words  Diabetes - retinopathy - hypophysectomy - ADP induced platelet aggregation - ristocetin induced platelet aggregation - Von Willebrand factor - antihemophilic procoagulant factor

Supported by a grant from the Institut National de la Santé et de la Recherche Médicale (I.N.S.E.R.M.)
Presented in part at the EASD 10th Annual Meeting, Jerusalem, 1974
Chargée de Recherche au C.N.R.S.

Fulltext Preview

Image of the first page of the fulltext document